Cargando…

Decision-making by p53 and mTOR

Detalles Bibliográficos
Autor principal:	Maki, Carl G.
Formato:	Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2010
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919249/ https://www.ncbi.nlm.nih.gov/pubmed/20603526

Ejemplares similares

mTOR favors senescence over quiescence in p53-arrested cells
por: Schug, Thaddeus T.
Publicado: (2010)

As expected, based on rapamycin-like p53-mediated gerosuppression, mTOR inhibition acts as a checkpoint in p53-mediated tumor suppression
por: Blagosklonny, Mikhail V.
Publicado: (2022)

mTOR and its link to the picture of Dorian Gray - re-activation of mTOR promotes aging
por: Węsierska-Gądek, Józefa
Publicado: (2010)

Be quiet and you'll keep young: does mTOR underlie p53 action in protecting against senescence by favoring quiescence?
por: Dulic, Vjekoslav
Publicado: (2011)

T memory stem cell formation: Caveat mTOR
por: Fowler, Daniel H., et al.
Publicado: (2016)

Regulation of the mTOR-Rac1 axis in platelet function
por: Aslan, Joseph E., et al.
Publicado: (2012)

Mechanistic insights into the role of mTOR signaling in neuronal differentiation
por: Bateman, Joseph M
Publicado: (2015)

Elucidating the role of Lkb1 and mTOR in adipose tissue
por: Xu, Ziye, et al.
Publicado: (2018)

YAP enters the mTOR pathway to promote tuberous sclerosis complex
por: Liang, Ning, et al.
Publicado: (2015)

p53 suppresses carcinoma progression by inhibiting mTOR pathway activation
por: Akeno, Nagako, et al.
Publicado: (2014)

mTORC2, the “other” mTOR, is a new player in energy balance regulation
por: Cota, Daniela
Publicado: (2014)

Normalizing a hyperactive mTOR initiates muscle growth during obesity
por: Williamson, David L., et al.
Publicado: (2011)

mTOR inhibition: a double-edged sword in patients with COVID-19?
por: Ghasemnejad-Berenji, Morteza
Publicado: (2021)

mTOR pathway activation in age-related retinal disease
por: Zhao, Chen, et al.
Publicado: (2011)

mTOR inhibition acts as an unexpected checkpoint in p53-mediated tumor suppression
por: Kon, Ning, et al.
Publicado: (2021)

Coordination of the AMPK, Akt, mTOR, and p53 Pathways under Glucose Starvation
por: Zhou, Yifan, et al.
Publicado: (2022)

The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway
por: Korotchkina, Lioubov G., et al.
Publicado: (2010)

p53 Inhibition Protects against Neuronal Ischemia/Reperfusion Injury by the p53/PRAS40/mTOR Pathway
por: Zhao, Jianlan, et al.
Publicado: (2021)

mTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53
por: Jung, Seung Hee, et al.
Publicado: (2018)

The Cross Talk Between p53 and mTOR Pathways in Response to Physiological and Genotoxic Stresses
por: Cui, Danrui, et al.
Publicado: (2021)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

PI3K/AKT/mTOR pathway in tumor progression of oligodendrogliomas
por: Lisi, Lucia
Publicado: (2020)

mTOR Links Environmental Signals to T Cell Fate Decisions
por: Chapman, Nicole M., et al.
Publicado: (2015)

mTOR-dependent autophagy contributes to end-organ resistance and serves as target for treatment in autoimmune disease
por: Perl, Andras
Publicado: (2018)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Estrogen Receptor-Alpha and p53 Status as Regulators of AMPK and mTOR in Luminal Breast Cancer
por: Gandhi, Nishant, et al.
Publicado: (2021)

Overcoming mTOR Resistance Mutations with a New Generation mTOR Inhibitor
por: Rodrik-Outmezguine, Vanessa S., et al.
Publicado: (2016)

Clinical implications of recent studies using mTOR inhibitors to treat advanced hormone receptor-positive breast cancer
por: Arena, Francis
Publicado: (2014)

PAK4-relevant proliferation reduced by cell autophagy via p53/mTOR/p-AKT signaling
por: Li, Qing, et al.
Publicado: (2023)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017)

Potential of mTOR inhibitors for the treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex
por: Major, Philippe
Publicado: (2011)

Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer
por: Cao, Guo-dong, et al.
Publicado: (2016)

From shared decision making to patient-centered decision making
por: Fineberg, Harvey V
Publicado: (2012)

The Interfaces Between Signal Transduction Pathways: IGF-1/mTor, p53 and the Parkinson Disease Pathway
por: Levine, Arnold J., et al.
Publicado: (2012)

Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinoma
por: Kong, Bo, et al.
Publicado: (2015)

mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19
por: Ramaiah, Mekala Janaki
Publicado: (2020)

UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma
por: Zhu, Jinhong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3nqlaudo7uiojad7o0ii4at07e